This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Colucci, M Articles by Mancardi, G L Search for Related Content PubMed PubMed Citation Articles by Colucci, M Articles by Mancardi, G L Social Bookmarking                         What's this?

The 14-3-3 protein in multiple sclerosis: a marker of disease severity

Department of Neuroscience, Ophthalmology and Genetic and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy

L Roccatagliata

Department of Neuroscience, Ophthalmology and Genetic and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy

E Capello

Department of Neuroscience, Ophthalmology and Genetic and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy

E Narciso

Department of Neuroscience, Ophthalmology and Genetic and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy

N Latronico

Istituto di Anestesia e Rianimazione, University of Brescia, Piazzale Spedali Civili 1, 25125 Brescia, Italy

M Tabaton

Department of Neuroscience, Ophthalmology and Genetic and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy, mtabaton{at}neurologia.unige.it

G L Mancardi

Department of Neuroscience, Ophthalmology and Genetic and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy

Context: In multiple sclerosis (MS) axonal damage is an early event and is probably to be considered the most relevant cause of permanent and progressive disability. Objectives: To investigate the value of the increase of 14-3-3 and tau proteins in the cerebrospinal fluid (CSF) as peripheral markers of axonal pathology and predictors of disease evolution. Patients and methods: In the CSF samples obtained from 63 patients with demyelinating diseases (DD), including 20 clinically isolated syndromes (CIS) and 43 clinically defined MS, as well as from 56 controls, we analysed the presence of 14-3-3 reactivity by immunoblot analysis along with the concentration of tau protein by sandwich ELISA. Results: The percentage of DD subjects showing a positive 14-3-3 protein CSF reactivity (38%) was significantly higher than the one previously detected, and was correlated in the MS patients with a more severe clinical phenotype in terms of degree of disability and rate of disease progression, during a 10-month mean clinical follow-up. On the contrary, the levels of the CSF-tau protein were highly variable in DD and control subjects, and the mean CSF-tau concentration was similar in both groups. Conclusions: The immunoblot analysis of 14-3-3 protein in the CSF could be a useful marker to identify a subgroup of DD patients with high risk of developing severe disability.

Key Words: 14-3-3 protein • cerebrospinal fluid • multiple sclerosis • tau protein

Multiple Sclerosis, Vol. 10, No. 5, 477-481 (2004)
DOI: 10.1191/1352458504ms1089oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. M. A. Moreira, T. Shen, G. Ohlsson, P. Gromov, I. Gromova, and J. E. Celis A Combined Proteome and Ultrastructural Localization Analysis of 14-3-3 Proteins in Transformed Human Amnion (AMA) Cells: Definition of A Framework to Study Isoform-Specific Differences Mol. Cell. Proteomics, July 1, 2008; 7(7): 1225 - 1240. [Abstract] [Full Text] [PDF]

				J Guimaraes, M J Cardoso, and M J Sa Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis Multiple Sclerosis, June 1, 2006; 12(3): 354 - 356. [Abstract] [PDF]